MedPath

THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH

THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH logo
🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:2
Completed:2

Trial Phases

4 Phases

Phase 1:3
Phase 2:4
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (30.8%)
Phase 2
4 (30.8%)
Phase 1
3 (23.1%)
Phase 3
2 (15.4%)

Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Not yet recruiting
Conditions
Stroke Patients
Stroke
Stroke; Sequelae
Young Adults
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
100
Registration Number
NCT07019493
Locations
🇦🇺

Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, Heidelberg, Victoria, Australia

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

Phase 2
Recruiting
Conditions
Amyotrophic Lateral Sclerosis
Interventions
Drug: Placebo
First Posted Date
2023-07-25
Last Posted Date
2023-09-07
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
50
Registration Number
NCT05959850
Locations
🇦🇺

Brain and Mind Centre, Sydney, New South Wales, Australia

🇦🇺

Concord Repatriation General Hospital, Sydney, New South Wales, Australia

🇦🇺

Flinders Medical Centre, Adelaide, South Australia, Australia

and more 2 locations

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke

Phase 2
Suspended
Conditions
Acute Ischemic Stroke
Interventions
First Posted Date
2022-05-05
Last Posted Date
2025-06-05
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
80
Registration Number
NCT05363397
Locations
🇦🇺

Timothy Ang, Camperdown, New South Wales, Australia

🇦🇺

Liverpool Hospital, Liverpool, New South Wales, Australia

🇦🇺

John Hunter Hospital, New Lambton Heights, New South Wales, Australia

and more 3 locations

Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

Phase 2
Terminated
Conditions
Insomnia
Alcohol Use Disorder
Interventions
First Posted Date
2019-04-01
Last Posted Date
2023-02-15
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
22
Registration Number
NCT03897062
Locations
🇦🇺

St Vincent's Hospital, Melbourne, Victoria, Australia

Cognition And Neocortical Volume After Stroke

Completed
Conditions
Alzheimer's Disease
Ischaemic Stroke
Vascular Dementia
First Posted Date
2014-07-31
Last Posted Date
2022-06-10
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
175
Registration Number
NCT02205424
Locations
🇦🇺

Eastern Health, Box Hill, Victoria, Australia

🇦🇺

Austin Health, Heidelberg, Victoria, Australia

🇦🇺

Melbourne Health, Parkville, Victoria, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.